HROW
Harrow Health Inc

3,387
Mkt Cap
$1.27B
Volume
511,498.00
52W High
$54.85
52W Low
$20.85
PE Ratio
-207.95
HROW Fundamentals
Price
$35.20
Prev Close
$34.00
Open
$33.77
50D MA
$44.24
Beta
1.43
Avg. Volume
551,403.15
EPS (Annual)
-$0.1398
P/B
24.14
Rev/Employee
$730,034.85
$1,979.96
Loading...
Loading...
News
all
press releases
HC Wainwright Issues Positive Outlook for Harrow Earnings
Harrow, Inc. (NASDAQ:HROW - Free Report) - Investment analysts at HC Wainwright raised their Q3 2026 earnings per share (EPS) estimates for shares of Harrow in a research report issued on Thursday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Harrow (HROW) to Release Quarterly Earnings on Thursday
Harrow (NASDAQ:HROW) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research
BTIG Research reissued a "buy" rating and set a $63.00 target price on shares of Harrow in a research note on Wednesday...
MarketBeat·6d ago
News Placeholder
Penn Capital Management Company LLC Makes New Investment in Harrow, Inc. $HROW
Penn Capital Management Company LLC purchased a new stake in Harrow, Inc. (NASDAQ:HROW - Free Report) during the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·6d ago
News Placeholder
307,337 Shares in Harrow, Inc. $HROW Bought by Luxor Capital Group LP
Luxor Capital Group LP purchased a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·7d ago
News Placeholder
Braidwell LP Decreases Stock Position in Harrow, Inc. $HROW
Braidwell LP trimmed its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 60.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·10d ago
News Placeholder
HC Wainwright Issues Negative Forecast for Harrow Earnings
Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities research analysts at HC Wainwright reduced their Q1 2026 earnings per share estimates for Harrow in a report issued on Wednesday, March 4th. HC...
MarketBeat·18d ago
News Placeholder
HC Wainwright Has Pessimistic Outlook of Harrow Q3 Earnings
Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at HC Wainwright decreased their Q3 2026 earnings per share (EPS) estimates for shares of Harrow in a research note issued to investors...
MarketBeat·19d ago
News Placeholder
Harrow (NASDAQ:HROW) Rating Lowered to "Strong Sell" at Zacks Research
Zacks Research lowered Harrow from a "hold" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat·19d ago
News Placeholder
Cantor Fitzgerald Lowers Harrow (NASDAQ:HROW) Price Target to $91.00
Cantor Fitzgerald lowered their price target on shares of Harrow from $94.00 to $91.00 and set an "overweight" rating for the company in a research report on Wednesday...
MarketBeat·20d ago
<
1
2
...
>

Latest HROW News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.